COVID-19 treatment: FDA says hydroxychloroquine touted by Trump is not safe or effective

COVID-19 treatment: FDA says hydroxychloroquine touted by Trump is not safe or effective

The Food and Drug Administration is warning against the use of two drugs President Donald Trump has repeatedly touted as a possible "game changer" in the fight against the coronavirus.

The Drug Safety Communication published Friday said the agency cautions against the use of hydroxychloroquine or chloroquine for COVID-19 treatment outside of hospitals or clinical trials due to the risk of heart rhythm problems.

"Hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing COVID-19," the FDA warned. Both can cause abnormal heart rhythms and a dangerously rapid heart rate, the statement said.

The FDA explicitly warned consumers not buy the drugs from online pharmacies without a prescription from a health care professional. "Consumers should not take any form of chloroquine that has not been prescribed for them by a healthcare professional," the agency stated on its website.

Trump virus claims:From malaria drugs to disinfectant: Here are some of Trump's claims about the coronavirus

'Our moon shot': The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years.

The FDA communication may bring an end to confusing and unsubstantiated claims about the two drugs. They began with tiny anecdotal studies in China, were amplified by an eccentric French microbiologist who likes to tweak the establishment and made their way to the White House where the president repeatedly suggested the drugs might help, saying, "What have you got to lose?"

"This is an important and timely statement from the FDA," said Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital and professor at Harvard Medical School.

"It reminds clinicians and the public that there are no proven or FDA approved treatments for COVID-19, and highlights the potential side effects of hydroxychloroquine and chloroquine, including serious and life-threatening heart rhythm problems."

Wayne Myers, a pharmacist at Norland Avenue Pharmacy, said Hydroxychloroquine works in a number of ways and has different medical uses.

No scientific evidence

Hydroxychloroquine and chloroquine are FDA-approved to treat or prevent malaria. Hydroxychloroquine is also FDA-approved to treat autoimmune conditions such as lupus and rheumatoid arthritis.

Doctors, including director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, have cautioned for months that without well-run clinical trials it is impossible to know if either drug is effective – or safe – to treat COVID-19, the disease caused by the new coronavirus.

While multiple clinical trials testing the drugs' efficacy and safety in COVID-19 patients are underway, early results indicatethe answer is no.

A study posted on April 21 involving 368 patients with confirmed cases of COVID-19 treated at Veterans Health Administration medical centers found there were more deaths among those given hydroxychloroquine than those receiving standard care. In addition, the drug made no difference in the need for a breathing machine.

"These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs," the study authors said.

A Brazilian double-blind research study published last week found chloroquine to be so dangerous at high doses the trial was shut down after six days.

The study found one-quarter of the patients taking the anti-malaria medication developed potentially deadly changes in the electrical system regulating their heartbeats. While a small and imperfect study, it highlighted the compelling need for more rigorous data.

To take or not to take

Both drugs have had had a rocky history in the months since the COVID-19 pandemic began to sweep the globe.

There were small, anecdotal, non-peer reviewed reports about the drugs in China as early in February. None wereup to the scientific gold standard of a double-blind, randomized, placebo-controlled trial that would definitively show they worked or not.

Interest in them took off when a controversial microbiologist in France posted a video on Feb. 25 promoting the use of hydroxychloroquine to treat COVID-19. Didier Raoult, has denied climate change is happening and wrote a book declaring Darwin's theory of evolution was wrong.

He then posted two small studies of the drugs on COVID-19 patients that were quickly criticized by scientists because they had no control group, making it impossible to know if people who got the drugs recovered any faster than those who didn't.

Television doctor Mehmet Oz initially supported the drug multiple times on Fox and Friends but this week began backing away from it.

Trump first spoke about hydroxychloroquine given together with the antibiotic azithromycin on March 19. He went on to tout them numerous times in various media and public events.

On April 13 he announced his administration had deployed roughly 28 million doses of hydroxychloroquine from the National Stockpile. "Just recently, a friend of mine told me he got better because of the use of that, that drug," he said in a briefing.

Trump has since toned down his support of the drugs. On Thursday he floated the idea of using "light inside the body" and studying the use of disinfectants "by injection." His comments triggered an urgent warning from the maker of Lysol that "under no circumstances" should its product be used as treatment.

The FDA's statement Friday is only the latest in the scientific community urging the need for more study of two drugs that are known to cause significant side effects

"It may also be worth noting that there are over 40 side effects associated with hydroxychloroquine dosage. These include dry cough, hoarseness, fever, difficulty breathing and increased incidence of cardiac arrhythmia," said John Scott, chair of the department of pharmacology at the University of Washington School of Medicine.

The U.S. Centers for Disease Control and Prevention abruptly switched its guidance for use of hydroxychloroquine on April 7, dropping its reference to anecdotal dosages to say simply that there are no approved drugs for dealing with the disease.

The CDC's online advice for hydroxychloroquine was updated three days after Reuters reported the CDC was offering what the news agency called "highly unusual guidance" for the drug's use based on "unattributed anecdotes rather than peer-reviewed science."

On April 11 the Infectious Diseases Society of America guidelines panel recommended patients hospitalized with COVID-19 be given chloroquine or hydroxychloroquine in the context of a clinical trial.

The FDA statement will be helpful to doctors, said Daniel Kaul, a professor of infectious disease at the University of Michigan medical school.

"This kind of taking a step back is taking the politics out of it, letting clinical trials move forward so we can figure out if there is any effect, what the safety profile is, in what situation might the drugs be helpful or harmful," he said.

In a clinical trial, patients are very carefully taken through an informed consent process where they're given information about all the potential risks and benefits, known side effects and other issues.

That context is "a much more comfortable place for us as doctors," Kaul said. "It will be helpful in communicating with patients and their families, who are desperate for a treatment. We can say 'The FDA is concerned and says these drugs should only be given in clinical trials.'"


News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »